Oramed Pharmaceuticals Inc.
Pharmaceutical company · New York, United States · Nasdaq: ORMP
Oramed Pharmaceuticals Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker ORMP. It has reported private securities offerings to the US SEC, most recently $31,500 sold in a notice filed in 2013.
Oramed Pharmaceuticals at a glance
What does Oramed Pharmaceuticals do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $31,500 sold (2013).
Frequently asked questions about Oramed Pharmaceuticals
Where is Oramed Pharmaceuticals headquartered?
Oramed Pharmaceuticals Inc. is headquartered in New York, United States.
What does Oramed Pharmaceuticals do?
Oramed Pharmaceuticals Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Oramed Pharmaceuticals a public company?
Yes. Oramed Pharmaceuticals Inc. trades on Nasdaq under the ticker ORMP.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences